CalcMyPeptide
Longevity & Anti-AgingAlso known as: HN, Mitochondrial Peptide Humanin

Humanin

Mitochondrial-derived peptide with cytoprotective properties — companion to MOTS-c in the mitokine family.

Half-Life
~30 minutes
Dose Range
1-5 mg/day (research)
Frequency
1× daily
Vial Sizes
5 mg

🔬 Mechanism of Action

Humanin (HN) is a 24-amino-acid mitochondrial-derived peptide (MDP), encoded by the 16S ribosomal RNA gene in mitochondrial DNA. It is the founding member of the "mitokine" family alongside MOTS-c.

Humanin has potent cytoprotective effects: it blocks apoptosis by binding IGFBP-3 and BAX (pro-apoptotic proteins), activates STAT3 signaling for cell survival, and provides neuroprotection against β-amyloid toxicity (Alzheimer's disease model). Circulating humanin levels decline with age, correlating with increased susceptibility to metabolic and neurodegenerative disease.

Source: PMID: 11555613

📜Background & History

Humanin is a 21-amino-acid mitochondria-derived peptide (MDP) discovered in 2001 by Nishimoto et al. (BBRC) while screening a human brain cDNA library for factors protecting against Alzheimer's-related neuronal death. It is encoded in the 16S rRNA region of mitochondrial DNA — like MOTS-c — making both of these peptides part of the emerging class of "mitokines" (mitochondria-derived signaling peptides). Circulating humanin levels decline with age and predict metabolic and cognitive health outcomes.

🎯 Research Use Cases

  • Alzheimer's disease neuroprotection (the original discovery context)
  • Insulin sensitization and type 2 diabetes prevention
  • Cardiovascular protection during ischemia
  • Longevity: circulating humanin is a positive longevity biomarker
  • Testicular function preservation during chemotherapy

💉 Dosing Protocol

Typical Dose1-5 mg/day (research)
Frequency1× daily
Half-Life~30 minutes
Common Vial Sizes5 mg

🧪 Reconstitution Example

Vial
5 mg
Water
2 mL
Concentration
2.5 mg/mL
Per Unit (100u syringe)
25 mcg
Dose of 1000 mcg = 40 units on a 100-unit insulin syringe

⚠️Safety & Considerations

Endogenous mitochondrial peptide. Limited human clinical data but strong preclinical safety. Research peptide status. May affect insulin sensitivity — monitor if diabetic.

Interactions & Contraindications

Limited human safety data. IGF-1 receptor signaling involvement — potential theoretical interaction with IGF-1 LR3. No significant drug interactions documented in available research. Injectable form preferred (oral stability uncertain).

🔗Synergies & Common Stacks

+ MOTS-c

Both are mitochondrial-derived peptides with complementary effects: MOTS-c optimizes metabolic function; Humanin provides cytoprotection and apoptosis inhibition. Core mitochondrial peptide stack.

+ SS-31

SS-31 protects the inner mitochondrial membrane; Humanin signals systemically as a cytoprotective mitokine. Comprehensive mitochondrial health and protection.

Humanin dosing guide infographic showing dose range 1-5 mg/day (research), half-life ~30 minutes, and reconstitution example
Humanin dosing quick reference — 1-5 mg/day (research), 1× daily

Frequently Asked Questions

How is Humanin related to MOTS-c?
Both are mitochondrial-derived peptides (MDPs) encoded in mitochondrial DNA. MOTS-c activates AMPK for metabolic regulation, while Humanin blocks apoptosis for cellular protection. They represent different arms of mitochondrial signaling.
Why do Humanin levels decline with age?
Mitochondrial DNA copy number and mitochondrial function both decline with age. Since Humanin is encoded in mtDNA, its production decreases accordingly. This decline correlates with increased susceptibility to age-related diseases.

📖 References

  1. Hashimoto Y, et al. Humanin is a neuroprotective mitochondrial-derived peptide.” Proc Natl Acad Sci USA (2001). PMID: 11481436
  2. Yen K, et al. Humanin and age-related diseases.” Biochim Biophys Acta (2013). PMID: 23291260

📚 Related Articles